| Genesis Rehab Services | |
|
255 E Main St, Moorestown, NJ 08057-2982 | |
| (267) 269-6119 | |
| Not Available |
| Full Name | Genesis Rehab Services |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 255 E Main St, Moorestown, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063995645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Genesis Rehab Services 2400 Mcclellan Ave Apt E714, Pennsauken, NJ 08109-7625 Ph: () - | Genesis Rehab Services 255 E Main St, Moorestown, NJ 08057-2982 Ph: (267) 269-6119 |
News Archive
Non-cardiac drugs that interfere with the electrical activity controlling the heartbeat are associated with a three-fold risk of sudden cardiac death, according to Dutch research published (Wednesday 11 May) in Europe's leading cardiology journal, the European Heart Journal.
The GOP-controlled legislature narrowly approved the compromise that would use federal funds to buy private insurance for low-income residents.
The UK National Health Service could save millions of pounds a year by routinely using inexpensive dressings to treat venous leg ulcers, after a study published in the October issue of BJS showed that they are just as effective as expensive silver dressings in the majority of cases.
Researchers are now saying that chemotherapy with drugs called aromatase inhibitors is unnecessary after lumpectomy, radiation and 5 years of Tamoxifen, for the vast majority of women with breast cancer.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.
› Verified 7 days ago
Brain Matters Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 505 S Lenola Rd Ste 202, Moorestown, NJ 08057 Phone: 856-206-9358 | |
Jessica Horning, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 401 Young Ave Ste 255, Moorestown, NJ 08057 Phone: 856-282-0336 Fax: 856-243-3926 | |
Miss Katie Jo Galezniak, MS, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 212 Marter Ave, Moorestown, NJ 08057 Phone: 856-291-4800 | |
Christie Fleming, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 212 Marter Ave, Moorestown, NJ 08057 Phone: 856-291-4816 | |
Emily N Panciera, MSOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 505 S Lenola Rd Ste 207, Moorestown, NJ 08057 Phone: 856-539-2987 | |
Ms. Maureen Castello, OTR,OTD/CHT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 132 West Main Street, Moorestown, NJ 08057 Phone: 856-234-4397 |